Results 11 to 20 of about 896,666 (294)
In “Cardiogenic Shock” (Indonesian Journal of Cardiology, 43(2), 90-9. https://doi.org/10.30701/ijc.1505), there are an errors noted. An error has been found in the PDF version of this article. The DOI printed in the PDF is incorrect. The correct DOI
H. P. Bagaswoto +5 more
doaj +10 more sources
Microcirculatory dysfunction in cardiogenic shock
Cardiogenic shock is usually defined as primary cardiac dysfunction with low cardiac output leading to critical organ hypoperfusion, and tissue hypoxia, resulting in high mortality rate between 40% and 50% despite recent advances.
Hamid Merdji +5 more
doaj +2 more sources
Aim The management of cardiogenic shock remains a clinical challenge even in well‐developed healthcare systems, best illustrated by its high mortality despite numerous innovative proposals for management.
Benedikt Schrage +12 more
doaj +2 more sources
Mechanical circulatory support in cardiogenic shock
Cardiogenic shock is a complex and diverse pathological condition characterized by reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve abnormal hemodynamics and maintain adequate tissue perfusion in organs.
Jun Nakata +5 more
doaj +2 more sources
To review the cause, epidemiology, pathophysiology, and treatment of cardiogenic shock.A MEDLINE search of the English-language reports published between 1976 and 1998 and a manual search of bibliographies of relevant papers.Experimental, clinical, and basic research studies related to cardiogenic shock.Data in selected articles were reviewed, and ...
Elias Knobel
doaj +8 more sources
Cyrus Vahdatpour +2 more
doaj +6 more sources
BackgroundEarly revascularization of the culprit vessel is the most effective treatment for reducing the risk of mortality from acute STEMI with and without cardiogenic shock.
Jing Wu +6 more
doaj +1 more source
Describing and Classifying Shock: Recent Insights
Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing array of percutaneous mechanical circulatory support devices. Mortality for cardiogenic shock has not changed meaningfully in more than 20 years.
Ashleigh Long +3 more
doaj +1 more source
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
This is a focused review looking at the pharmacological support in cardiogenic shock. There are a plethora of data evaluating vasopressors and inotropes in septic shock, but the data are limited for cardiogenic shock.
Aditi Shankar +6 more
doaj +1 more source
Practical aspects of managing patients with cardiogenic shock
Cardiogenic shock is the leading cause of death among patients with acute coronary syndrome. This pathology is characterized by high rates of inhospital and annual mortality.
M. M. Novosadov +3 more
doaj +1 more source

